MoneyWorks4Me

Raymed Labs - Quaterly Results

12 Aug 2024 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended June 2024. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -0.18 millions as compared to Net Loss of Rs. -0.16 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 further decreased to -0.16% as compared to -0.15% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00
PBIDT -0.16 -0.15 6.67 -0.16 -0.15 6.67 -0.97 -1.65 -41.21
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.16 -0.15 6.67 -0.16 -0.15 6.67 -0.97 -1.65 -41.21
Depreciation 0.02 0.01 100.00 0.02 0.01 100.00 0.05 0.06 -16.67
PBT -0.18 -0.16 12.50 -0.18 -0.16 12.50 -1.02 -1.71 -40.35
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.18 -0.16 12.50 -0.18 -0.16 12.50 -1.02 -1.71 -40.35
Equity 42.74 42.74 0.00 42.74 42.74 0.00 42.74 42.74 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Uflex 663.05
EPL 238.55
AGI Greenpac 803.90
Huhtamaki India 242.40
TCPL Packaging 4107.35
View more..